A rapid and simple method for simultaneous determination of three breast cancer related microRNAs based on magnetic nanoparticles modified with S9.6 antibody

Ghanbari, Reza; Isfahani, Ali Attaripour; Pirmoradian, Sina; Rezaei, Hadi; Radfar, Sasan; Kheirollahi, Majid

doi:10.1016/j.ab.2023.115052

Cited by 5 publications

(3 citation statements)

References 38 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The HC-ELISA assay is simple and can be adopted into sentinel labs, reference labs and national laboratories for pathogen detection to detect active infection at low cost. As this manuscript was prepared for submission, new reports on the use of S9.6 in diagnostics emerged, supporting our ndings that it can be adopted for detecting any gene or transcript speci c to a disease or pathogen (13)(14)(15).…”

Section: Discussionsupporting

confidence: 65%

See 1 more Smart Citation

S9.6-based hybrid capture immunoassay for pathogen detection

Bothra,

Perry,

Wei

et al. 2023

Preprint

View full text Add to dashboard Cite

The detection of pathogens is critical for clinical diagnosis and public health surveillance. Detection is usually done with nucleic acid-based tests (NATs) and rapid antigen tests (e.g., lateral flow assays [LFAs]). Although NATs are more sensitive and specific, their use is often limited in resource-poor settings due to specialized requirements. To address this limitation, we developed a rapid DNA-RNA Hybrid Capture immunoassay (HC) that specifically detects RNA from pathogens. This assay utilizes a unique monoclonal antibody, S9.6, which binds DNA-RNA hybrids. Biotinylated single-stranded DNA probes are hybridized to target RNAs, followed by hybrid capture on streptavidin and detection with S9.6. The HC-ELISA assay can detect as few as 104 RNA molecules that are 2.2 kb in length. We also adapted this assay into a LFA format, where captured Bacillus anthracis rpoB RNA of 3.5 kb length was detectable from a bacterial load equivalent to 107 CFU per 100 mg of mouse tissue using either HC-ELISA or HC-LFA. Importantly, we also demonstrated the versatility of HC by detecting other pathogens, including SARS-CoV2 and Toxoplasma gondii, showing its potential for broad pathogen detection. Notably, HC does not require amplification of the target nucleic acid and utilizes economical formats like ELISA and LFA, making it suitable for use in sentinel labs for pathogen detection or as a molecular tool in basic research laboratories. Our study highlights the potential of HC as a sensitive and versatile method for RNA-based pathogen detection.

show abstract

Section: Discussionsupporting

confidence: 65%

“…Various low-cost techniques, including LFA and ELISA, have been developed to detect disease-speci c nucleic acids (5,10,(13)(14)(15). One example is the HC2-HPV diagnostic assay for human papillomavirus (HPV) infection marketed by Qiagen (Digene), which employs polyclonal antibodies in a "hybrid capture" sandwich ELISA format (16,17).…”

Section: Introductionmentioning

confidence: 99%

S9.6-based hybrid capture immunoassay for pathogen detection

Bothra,

Perry,

Wei

et al. 2023

Preprint

View full text Add to dashboard Cite

show abstract

“…Currently, conventional miRNA detection techniques include quantitative real-time polymerase chain reaction (qRT-PCR), RNA sequencing, northern blotting, and miRNA microarrays. However, these methods are limited by expensive equipment and complex and time-consuming experimental steps. , In recent years, further detection methods for miRNAs have been developed, including electrochemical detection, , electrochemical luminescence detection, , colorimetric analysis, and fluorescence detection. Among them, fluorescence detection is a highly sensitive, low-cost, easy-to-operate optical method for effective biological assays .…”

mentioning

confidence: 99%

Amplification-Free Analysis of Bladder Cancer MicroRNAs on Wrinkled Silica Nanoparticles with DNA-Functionalized Quantum Dots

Wang,

Wei,

Shen

et al. 2024

Anal. Chem.

View full text Add to dashboard Cite

Bladder cancer (BC) occurrence and progression are accompanied by alterations in microRNAs (miRNAs) expression levels. Simultaneous detection of multiple miRNAs contributes to the accuracy and reliability of the BC diagnosis. In this work, wrinkled silica nanoparticles (WSNs) were applied as the microreactor for multiplex miRNAs analysis without enzymes or nucleic acid amplification. Conjugated on the surface of WSNs, the S9.6 antibody was adopted as the universal module for binding DNA/miRNA duplexes, regardless of their sequence. Furthermore, single-stranded DNA (ssDNA) was labeled with quantum dots (QDs) for identifying a given miRNA to form QDs-ssDNA/ miRNA, which enabled the specific capture of the corresponding QDs on the wrinkled surface of WSNs. Based on the detection of fluorescence signals that were ultimately focused on WSNs, target miRNAs could be sensitively identified to a femtomolar level (5 fM) with a wide dynamic range of up to 6 orders of magnitude. The proposed strategy achieved high specificity to obviously distinguish single-base mutation sequences and possessed multiplex assay capability. Moreover, the assay exhibited excellent practicability in the multiplex detection of miRNAs in clinical serum specimens.

show abstract